neoX Biotech
PrivateLast Round
Series A
Extension
Jul 8, 2021
Total Funding Raised
$40M
Company Overview
neoX Biotech is a biotechnology company that integrates artificial intelligence, biophysics, and high-throughput experimentation to develop macromolecular and multi-specific drugs for immuno-oncology and other therapeutic areas.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
neoX Biotech Comparables
Compare neoX Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Degron Therapeutics | 79% | |
| BigHat Biosciences | 79% | |
| Beyang Therapeutics Co., Ltd. | 78% |
neoX Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 8, 2021 | ||||
| Series A | Feb 9, 2021 | ||||
| Pre Seed | Jul 6, 2020 | ||||
| Accelerator | Dec 1, 2019 | ||||
| Seed | Aug 24, 2018 | ||||
Seed | Jun 1, 2018 |
neoX Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yuanjing Capital | Series A, Series A Extension, Pre Seed |
| MiraclePlus | Series A Extension |
| ZhenFund | Angel, Seed |
| LYFE Capital | Series A Extension |
| Sky9 Capital | Series A Extension, Series A |
| Genesis Capital | Series A Extension |
| Sequoia Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 298% MoM, reaching 1.3K.
- Jul 8, 2021
Led by Genesis Capital and LYFE Capital.
neoX Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about neoX Biotech's valuation, stock price, and market status.
Is neoX Biotech a public or private company?
neoX Biotech is a private company.
What is the current stock price of neoX Biotech?
neoX Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is neoX Biotech worth (valuation)?
Valuation information for neoX Biotech is not publicly available.
Can I buy neoX Biotech stock?
neoX Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was neoX Biotech's last funding round?
neoX Biotech's most recent funding round was Series A Extension on July 8, 2021.
Who are the main investors in neoX Biotech?
Key investors in neoX Biotech include Vision Plus Capital, LYFE Capital, Sky9 Capital, Genesis Capital, 5Y Capital.
Will neoX Biotech IPO soon?
No public IPO plans have been announced for neoX Biotech.
How can I track neoX Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor neoX Biotech's secondary market activity and sign up for updates.